Why Moderna Stock Tanked on Tuesday

Why Moderna Stock Tanked on Tuesday

What happened Shares of Moderna (NASDAQ: MRNA) fell by almost 6% on Tuesday. While the company's mRNA-1273 remains one of only two coronavirus vaccines authorized by the Food and Drug Administration, its counterpart seems to be the one getting all the positive press lately.